The Lutropin/Choriogonadotropin Receptor-Induced Phosphorylation of the Extracellular Signal-Regulated Kinases in Leydig Cells Is Mediated by a Protein Kinase A-Dependent Activation of Ras
Authors:
- 1 November 2003
- journal article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 17 (11) , 2189-2200
Abstract
The pathways involved in activation of the ERK1/2 cascade in Leydig cells were examined in MA-10 cells expressing the recombinant human LH receptor (hLHR) and in primary cultures of rat Leydig cell precursors. In MA-10 cells expressing the recombinant hLHR, human choriogonadotropin-induced activation of ERK1/2 is effectively inhibited by overexpression of a cAMP phosphodiesterase (a manipulation that blunts the human choriogonadotropin-induced cAMP response), by addition of H89 (a selective inhibitor of protein kinase A), or by overexpression of the heat-stable protein kinase A inhibitor, but not by overexpression of an inactive mutant of this inhibitor. Stimulation of hLHR did not activate Rap1, but activated Ras in an H89-sensitive fashion. Addition of H89 to MA-10 cells that had been cotransfected with a guanosine triphosphatase-deficient mutant of Ras almost completely inhibited the hLHR-mediated activation of ERK1/2. We also show that 8-bromo-cAMP activates Ras and ERK1/2 in MA-10 cells and in primary cultures of rat Leydig cells precursors in an H89-sensitive fashion, whereas a cAMP analog 8-(4-chloro-phenylthio)-2′-O-methyl-cAMP (8CPT-2Me-cAMP) that is selective for cAMP-dependent guanine nucleotide exchange factor has no effect. Collectively, our results show that the hLHR-induced phosphorylation of ERK1/2 in Leydig cells is mediated by a protein kinase A-dependent activation of Ras.Keywords
This publication has 49 references indexed in Scilit:
- A Constitutively Active Somatic Mutation of the Human Lutropin Receptor Found in Leydig Cell Tumors Activates the Same Families of G Proteins as Germ Line Mutations Associated with Leydig Cell HyperplasiaEndocrinology, 2003
- Acute Signaling by the LH Receptor Is Independent of Protein Kinase C ActivationEndocrinology, 2002
- The Lutropin/Choriogonadotropin Receptor, A 2002 PerspectiveEndocrine Reviews, 2002
- Male LH-Independent Sexual Precocity in a 3.5-Year-Old Boy Caused by a Somatic Activating Mutation of the LH Receptor in a Leydig Cell TumorThe Journal of Clinical Endocrinology & Metabolism, 2002
- MA-10 Cells Transfected with the Human Lutropin/Choriogonadotropin Receptor (hLHR): A Novel Experimental Paradigm to Study the Functional Properties of the hLHREndocrinology, 2002
- The Association of Arrestin-3 with the Human Lutropin/Choriogonadotropin Receptor Depends Mostly on Receptor Activation Rather than on Receptor PhosphorylationJournal of Biological Chemistry, 2002
- Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal FunctionEndocrine Reviews, 2000
- Leydig-Cell Tumors Caused by an Activating Mutation of the Gene Encoding the Luteinizing Hormone ReceptorNew England Journal of Medicine, 1999
- Naturally Occurring Mutations of the Luteinizing-Hormone Receptor: Lessons Learned about Reproductive Physiology and G Protein–Coupled ReceptorsThe American Journal of Human Genetics, 1999
- Activation of Mitogen-Activated Protein Kinases by Gonadotropins and Cyclic Adenosine 5’-Monophosphates in Porcine Granulosa Cells1Biology of Reproduction, 1996